Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Osiris Therapeutics awarded SBIR grant for tendon regeneration research

March 17, 1997

Genzyme Transgenics and Fresenius to further development of transgenic albumin

March 17, 1997

MGI Pharma and Schein reach marketing agreement for INFeD

March 14, 1997

MP-52 enters clinic

March 14, 1997

Combination of immunosuppression and rhIL-3 for aplastic anemia

March 14, 1997

SKB discloses improved antihyperlipidemic agent

March 13, 1997

Advanced-generation matrix HRT patch launched in U.K.

March 12, 1997

Green Cross claims hypolipidemic agents

March 12, 1997

Recombinant human hemoglobin produced by transgenic tobacco

March 11, 1997

Millennium obesity gene patent application receives U.S. notice of allowance

March 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...